Both of Germany’s chambers of parliament have now passed the diagnosis related groups (DRGs) and hospital reform bill (the Krankenhausversorgungsverbesserungsgesetz – KHVVG), which will come into force in stages as of 1 January 2025. Provisions will continue to be introduced piecemeal until 2029.
Germany’s DRGs And Hospital Reform Cleared For January Launch
Dissenters In Bundesrat Not Able To Muster Enough Support To Delay Bill
Germany’s governing coalition may have folded, but embattled health minister Lauterbach has championed his hospital reform bill to the last. Now voted through in the upper house of parliament, the bill to reform diagnosis related groups and hospital care delivery will come into force on 1 January.
More from Medica
• By
The UK market has become tougher for smaller innovators, says Andy Mears, CEO of Deltex Medical, which plans to launch a new iteration of its minimally invasive ultrasound-based technology, the oesophageal Doppler monitor. He explained how market access challenges have steepened.
• By
When federal chancellor Olaf Scholz lost his parliamentary vote of confidence in mid-December, it officially opened up the way for the elections the German leader had already penciled in for 23 February. The medtech industry has not been slow to set out its demands of the incoming government.
• By
The implosion of the German coalition government left unfinished business for the medtech industry. The coalition to emerge from the 23 February general election must consult more with industry, Spectaris’ head of medtech Marcus Kuhlmann said at Medica 2024.
• By
Germany’s governing coalition may have folded, but embattled health minister Lauterbach has championed his hospital reform bill to the last. Now voted through in the upper house of parliament, the bill to reform diagnosis related groups and hospital care delivery will come into force on 1 January.
More from Policy & Regulation
• By
Exer Labs Inc.’s website marketed its AI-based Exer Scan app to “screen and treat Parkinson’s, TB, Cerebral Palsy and more.” But those claims went well beyond what was allowed under the product’s 510(k) clearance, US regulators say.
• By
Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.
• By
People living with diabetes who receive continuous glucose monitors (CGMs) through medical supply firms show higher compliance, lower costs of care, and fewer hospitalizations after one year than those who use pharmacies, a new study shows.